MIRA INFORM REPORT

 

 

Report Date :

31st May 2006

 

IDENTIFICATION DETAILS

 

Name :

KYORITSU SEIYAKU CORPORATION

 

 

Registered Office :

1-5-10 Kudanminami Chiyodaku Tokyo 102-0074 Japan

 

 

Country :

Japan

 

 

Financials (as on) :

31/05/2006 (Estimated)

 

 

Date of Incorporation :

May 1955

 

 

Legal Form :

Limited Company

 

 

Line of Business :

Importers, exporters and wholesalers of veterinary medicines

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

YEN 526.6 MILLION

 

 

Status :

Satisfactory 

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear


 

NAME

 

KYORITSU SEIYAKU CORPORATION

 

 

REGD NAME

 

Kyoritsu Seiyaku KK (Seiyaku means Pharmaceuticals)

 

 

MAIN OFFICE

 

1-5-10 Kudanminami Chiyodaku Tokyo 102-0074 JAPAN

Tel: 03-3263-2931    

Fax: ^

URL:http://www.kyoritsuseiyaku.com/

E-Mail address: kyoritsu@kyoritsuseiyaku.com

 

 

ACTIVITIES

 

Import, export, wholesale of veterinary medicines

 

 

BRANCHES

 

Sapporo, Sendai, Saitama, Osaka, Nagoya, Okayama, Fukuoka, Kagoshima

 

 

FACTORY(IES)

 

Daiba (Tokyo), Samukawa (--warehousing)

 

 

OFFICER(S)  

 

Yuriko Takai, ch                                     YUHEI OKAMOTO, PRES

Takaaki Takai, v pres                              Seiichi Hirano, mgn dir

Susumu Furuuchi, dir                             Kazuhiro Fujita, dir

 

 

Yen Amount

 

In million Yen, unless otherwise stated

 

 

SUMMARY    

 

FINANCES        FAIR                             A/SALES                      Yen 13,506 M

PAYMENTS      REGULAR                     CAPITAL                       Yen 55 M

TREND             STEADY                       WORTH                        Yen 9,253 M

STARTED         1955                             EMPLOYES                  233

 

 

COMMENT

 

TRADING HOUSE SPECIALIZING VETERINARY MEDICINES.  FINANCIAL SITUATION CONSIDERED FAIR TO GOOD AND RESPONSIBLE FOR ORDINARY BUSINESS ENGAGEMENTS.

MAX CREDIT LIMIT: YEN 526.6 MILLION, NORMAL 30 DAYS TERMS.

 

 

HIGHLIGHTS

 

The subject company is a leading trading house specializing in animal medicines, established by Yuriko Takei’s husband.  Specializes in import and wholesale of veterinary drugs, all for prescription by veterinary surgeons, such as vaccine, vitamins, etc.  Also handles pulicide, antibacterial agents, anthelmintic agents, pet foods, supplement foods, all for animals.  Animal feeds are also handled.  Nation’s top-ranked wholesaler of animal drugs.  Have wide business tie-ups with overseas mfrs, such as Fort Dodge Animal Health, Master Foods, Inter-bet International, Abbot Laboratories, Animal Health Options, Addison Biological Laboratory, other.  Domestic clients include pharmaceuticals mfrs, wholesalers, other.

 

The sales volume for May/2005 fiscal term amounted to Yen 13,506 million, a 3.5% up from Yen 13,051 million in the previous term.  Demand for animal drugs grew rapidly amid pet booms nationwide.  The recurring profit was posted at Yen 1,451 million and the net profit at Yen 965 million, respectively, compared with Yen 1,282 million recurring profit and Yen 945 million net profit, respectively, a year ago.

For the current term ending May 2006 the recurring profit is projected at Yen 1,550 million and the net profit at Yen 1,030 million, respectively, on a 7.4% rise in turnover, to Yen 14,500 million.

The financial situation is considered FAIR to GOOD and responsible to ORDINARY business engagements.  Max credit limit is estimated at Yen 526.6 million, on normal 30 days terms.

 

 

REGISTRATION

 

Date Registered:            May 1955

Legal Status:                 Limited Company (Kabushiki Kaisha)

Authorized:                    280,000 shares

Issued:                          110,000 shares

Sum:                            Yen 55 million

Major shareholders (%): Yuriko Takai (54), Takaaki Takai (25), Yuhei Okamoto (10)

No. of shareholders: 17

Nothing detrimental is known as to the commercial morality of executives.

 

 

OPERATION

 

Activities: Imports and wholesales veterinary prescription animal drugs: vaccine, vitamin, antibacterial agents, anthelmintic agents, animal feeds, pet foods, supplement, other (--100%).

 

Clients: [Pharmaceutical firms, traders] Aesop Yakuhin, Morikubo Yakuhin, Asuko, Atol Co, Sun Daiko, Maruzen Yakuhin, other.

No. of accounts: 1,000

Domestic areas of activities: Nationwide

 

Suppliers: [Mfrs, wholesalers] Master Foods, Toray Ind, Kyowa Hakko Kogyo, other.  Goods are also imported.

Payment record: Regular

 

Location: Business area in Tokyo.  Office premises at the caption address are owned and maintained satisfactorily.

 

 

Bank References

 

Mizuho Bank (Jimbocho)

Bank of Tokyo-Mitsubishi UFJ (Shin-Marunouchi)

Relations: Satisfactory

 

 

FINANCES

 

(In Million Yen)

       Terms Ending:

31/05/2006

31/05/2005

31/05/2004

Annual Sales

 

14,500

13,506

13,051

Recur. Profit

 

1,550

1,451

1,282

Net Profit

 

1,030

965

945

Total Assets

 

 

14,861

15,603

Current Assets

 

 

9,107

9,713

Current Liabs

 

 

2,508

3,404

Net Worth

 

 

9,253

8,416

Capital, Paid-Up

 

 

55

55

Div.P.Share(¥)

 

 

 

 

<Analytical Data>

(%)

(%)

(%)

       S.Growth Rate

7.36

3.49

-8.86

       Current Ratio

 

..

363.12

285.34

       N.Worth Ratio

..

62.26

53.94

       R.Profit/Sales

 

10.69

10.74

9.82

       N.Profit/Sales

7.10

7.14

7.24

       Return On Equity

..

10.43

11.23

 

Notes: Forecast (or estimated) figures for the 31/05/2006 fiscal term.

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average/normal.

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

Credit not recommended

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions